Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06977347
NA

Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea

Sponsor: CHOSEOK YOON

View on ClinicalTrials.gov

Summary

This study aims to provide high-level evidence for appropriate empirical antibiotic use tailored to the clinical reality in Korea by conducting a randomized controlled trial comparing monotherapy with piperacillin/tazobactam and combination therapy with piperacillin/tazobactam plus a fluoroquinolone in patients with severe community-acquired pneumonia.

Official title: Verification of Anti-pseudomonal Antibiotic Combination Therapy in Severe Community-acquired Pneumonia in South Korea: A Randomized-controlled Study

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2025-06-15

Completion Date

2027-02-01

Last Updated

2025-05-18

Healthy Volunteers

No

Interventions

DRUG

Piperacillin/Tazobactam

Piperacillin/tazobactam: 4.5g IV q6h (over 3h)

DRUG

Piperacillin/tazobactam + Levofloxacin

Piperacillin/tazobactam: 4.5g IV q6h (over 3h) \+ Levofloxacin 750mg IV q24h (over 30min)

Locations (1)

Hanyang University Seoul Hospital

Seoul, Seoul, South Korea